Is Xtant Medical Holdings Inc (XTNT) overvalued? · rev $117.3M
Xtant Medical Holdings Inc (XTNT) is a medical devices company listed on US.
This page asks whether Xtant Medical Holdings Inc (XTNT) looks expensive on cached numbers — not a short thesis.
Latest reported XTNT revenue for 2024-12-31 was $117.3M. Net income was -$16.4M. Revenue was up 28.4% from 2023-12-31 to 2024-12-31. XTNT currently screens at market cap $91.0M.
XTNT currently screens at market cap $91.0M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next XTNT 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the XTNT stock page for the full model, not this heading.
Not investment advice.